Drugs / JST-018
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT07595458 Comparator | Jun → Nov 2026 expected | interferon antiviral depressor | Just-Evotec Biologics | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JST-018 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07595458 ↗ |
| Modality | Monoclonal antibody | “JST-018 combination of 3 monoclonal antibodies” NCT07595458 ↗ |
| Route | Intramuscular | “administered IM” NCT07595458 ↗ |